Skip to content

Legal status by country

Is Ziconotide legal?

Written by Reviewed Sep 2026

Nootropic & CNSHuman studies cited: 2

How Ziconotide is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.

All four countries, side by side

AttributeUnited States · FDAUnited Kingdom · MHRAAustralia · TGACanada · Health Canada
StatusApprovedApprovedApprovedApproved
ClassificationFDA-approved, prescription onlyLicensed, prescription only (MHRA)TGA-registered, prescription onlyHealth Canada approved, prescription only
NoteNDA 021060, approved 28 December 2004, marketed as Prialt. Prescription only, administered by intrathecal infusion in specialist pain services. Boxed warning for severe psychiatric symptoms and neurological impairment.Licensed as Prialt for severe chronic pain in patients who require intrathecal analgesia. Specialist use only; it is not a drug a general prescriber would initiate.Restricted to intrathecal use in specialist pain management. Not available in any other form.Restricted to intrathecal use in specialist pain management. Not available in any other form.

US FDA status: FDA-approved on 28 December 2004 under NDA 021060, for the management of severe chronic pain in adults for whom intrathecal therapy is warranted and who are intolerant of or refractory to other treatment. Intrathecal infusion is the only approved route. The label carries a boxed warning for severe psychiatric symptoms and neurological impairment.. Reviewed Sep 2026.

Related compounds

General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.